(Q35547178)

8 August 2017

Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation (English)

1 reference

8 August 2017

0 references

ten Wolde S

1

1 reference

8 August 2017

Hermans J

series ordinal

2

1 reference

8 August 2017

Breedveld FC

series ordinal

3

1 reference

8 August 2017

Dijkmans BA

series ordinal

4

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

Annals of the Rheumatic Diseases

8 August 2017

1 reference

8 August 2017

56

1 reference

8 August 2017

235-239

1 reference

8 August 2017

4

1 reference

The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

Long-term azathioprine in rheumatoid arthritis: a double-blind study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

Efficacy and toxicity of retreatment with gold salts: a retrospective review of 25 cases.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

D-penicillamine withdrawal in rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

Low-dose methotrexate in rheumatoid arthritis: effect and tolerance. An open trial and a double-blind randomized study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

Low dose, long-term treatment of rheumatoid arthritis with azathioprine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752349

Preliminary criteria for clinical remission in rheumatoid arthritis

12 July 2018

1 reference

12 December 2020

Second course gold therapy in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study

1 reference

12 December 2020

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

1 reference

12 December 2020

Response to sulfasalazine in rheumatoid arthritis: life table analysis of a 5-year followup

1 reference

12 December 2020

The second course of gold

1 reference

12 December 2020

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.56.4.235

1 reference

8 August 2017

1 reference

8 August 2017

1 reference